Literature DB >> 7844128

The effect of warfarin on the attachment of bone to hydroxyapatite-coated and uncoated porous implants.

B C Callahan1, E J Lisecki, R E Banks, J E Dalton, S D Cook, J D Wolff.   

Abstract

The attachment of bone to hydroxyapatite-coated and uncoated porous implants made of cobalt-chromium-molybdenum alloy was investigated with and without postoperative administration of warfarin sodium. The implants were placed transcortically in the femoral diaphysis of adult female goats and were evaluated after three, six, and twelve weeks in situ. Mechanical push-out testing and histological evaluation revealed that the attachment strength and the ingrowth of bone at the bone-implant interface increased with time in situ for both the hydroxyapatite-coated and the uncoated implants. The administration of warfarin significantly impaired both the attachment strength and the ingrowth of bone at twelve weeks. At twelve weeks, the attachment strength and bone ingrowth of the hydroxyapatite-coated implants in the animals that had received warfarin were statistically equal to those of the uncoated implants in the control animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844128     DOI: 10.2106/00004623-199502000-00008

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  2 in total

1.  The effect of a new oral anticoagulant (Rivaroxaban) on implants pull-out strength. An experimental study in rats.

Authors:  Artemis G Kapetanou; Matthaios S Savvidis; Michael E Potoupnis; George E Petsatodis; John M Kirkos; George A Kapetanos
Journal:  J Frailty Sarcopenia Falls       Date:  2017-03-01

2.  Postoperative Administration of Alpha-tocopherol Enhances Osseointegration of Stainless Steel Implants: An In Vivo Rat Model.

Authors:  Matthaios Savvidis; Kyriakos Papavasiliou; Ioannis Taitzoglou; Aggeliki Giannakopoulou; Dimitrios Kitridis; Nikiforos Galanis; Ioannis Vrabas; Eleftherios Tsiridis
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.